Interleukin-2
Drug timelines are a Plus or Pro feature.
183 regulatory and trial events tracked for Interleukin-2, covering 2007-01-22 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab [Phase 2]